Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295

Transplantation

Volumn 74, Issue 9, 2002, Pages 1335-1341

  Karck, Matthias ^a   Meliss, Rolf ^a   Hestermann, Michael ^a   Mengel, Michael ^a   Pethig, Klaus ^a   Levitzki, Alexander ^b   Banai, Shmuel ^b   Golomb, Gershon ^c   Fishbein, Ilia ^c   Chorny, Michael ^c   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIMETHYL 2 PHENYLQUINOXALINE; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; POLYMER; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; GENE EXPRESSION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; VASCULAR DISEASE;

EID: 0037112895     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200211150-00023     Document Type: Article

References (30)

1. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986; 46(2): 155.
2. Cercec B, Sharifi B, Barath P, et al. Growth factors in the pathogenesis of coronary arterial restenosis. Am J Cardiol 1991; 68: 24C.
3. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: Current concepts, recent developments, and future directions. J Heart Lung Transplant 1992; 11: 9.
4. Yarden Y, Ullrich A. Growth-factor receptor tyrosine kinases. Annu Rev Biochem 1988; 57: 443.
5. Levitzki A. Tyrphostins: Tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J 1992; 6: 3275.
6. Bilder GE, Krawiec JA, McVety K, et al. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am J Physiol 1992; 260: C721.
7. Kovalenko M, Gazit A, Bohmer A, et al. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 1994; 54 (23): 6106.
8. Kovalenko M, Rönnstrand L, Heldin CH, et al. Phosphorylation site-specific inhibition of PDGFβ-receptor autophosphorylation by the receptor blocking tyrphostin AG-1296. Biochemistry 1997; 36: 6260.
9. Fishbein I, Chrorny M, Banai S, et al. Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model. Arterioscler Thromb Vasc Biol 2001; 21: 1434.
10. Banai S, Wolf Y, Golomb G, et al. PDGF-receptor tyrosine kinase blocker AG-1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 1998; 97: 1960.
11. Fishbein I, Waltenberger J, Banai S, et al. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats. Arterioscler Thromb Vasc Biol 2000; 20: 667.
12. Sihvola R, Koskinen P, Myllarniemi M, et al. Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor. Circulation 1999; 99: 2295.
13. Golomb G, Fishbein I, Banai S, et al. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis 1996; 125: 171.
14. Golomb G, Langer R, Schoen FJ, et al. Controlled release of diphosphonate to inhibit bioprosthetic heart valve calcification: Dose response and mechanistic studies. J Control Release 1986; 4: 181.
15. Mennander A, Tiisala S, Halttunen J, et al. Chronic rejection in rat aortic allografts: An experimental model for transplant arteriosclerosis. Arterioscler Thromb Vasc Biol 1991; 11: 671.
16. Akyürek L, Funa K, Wanders A, Larsson E, Fellström B. Inhibition of transplant arteriosclerosis in rat aortic grafts by low molecular weight heparin derivatives. Transplantation 1995; 59: 1517.
17. von Wasielewski R, Mengel M, Gignac S, et al. Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 1997; 45 (11): 1455.
18. Delafontaine P, Brink M, Anwar A, et al. Growth factors and receptors in allograft arteriosclerosis. Transplant Proc 1999; 31: 111.
19. Hart CE, Clowes AW. Platelet-derived growth factor and arterial response to injury. Circulation 1997; 95: 555.
20. Hayry P. Chronic rejection: Risk factors, regulation, and possible sites of therapeutic intervention. Transplant Proc 1998; 30: 2407.
21. Lemmon-MA, Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci 1994; 19: 459.
22. Levitzki A, Gazit A. Tyrosine kinase inhibition: An approach to drug development. Science 1995; 267: 1782.
23. Buchdunger E, Zimmermann J, Mett H, et al. Selective inhibition of platelet-derived growth factor signal transduction pathway by proteintyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci USA 1995; 92: 2558.
24. Mennander A, Paavonen T, Hayry P. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated. Arterioscler Thromb Vasc Biol 1993; 13: 1019.
25. Legare JF, Issekutz T, Lee TD, et al. CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection. Am J Pathol 2000; 157: 859.
26. Akyürek LM, Paul LC, Funa K, Larsson E, Fellström B. Smooth muscle cell migration into intima and adventitia during development of transplant vasculopathy. Transplantation 1996; 62: 1526.
27. Bolling SF, Lin H, Annesley TM, et al. Local cyclosporine immunotherapy of heart transplants in rats enhances survival. J Heart Lung Transplant 1991; 4: 577.
28. Gottsauner-Wolf M, Jang J, Lincoff AM, et al. Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model. Am Heart J 1997; 133: 329.
29. Lemström KB, Koskinen PK. Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts. Circulation 1997; 96: 1240.
30. Golomb G, Fishbein I. Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis. Adv Drug Deliv Rev 1997; 24: 53.